BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 34197567)

  • 1. Using Plasmodium knowlesi as a model for screening Plasmodium vivax blood-stage malaria vaccine targets reveals new candidates.
    Ndegwa DN; Kundu P; Hostetler JB; Marin-Menendez A; Sanderson T; Mwikali K; Verzier LH; Coyle R; Adjalley S; Rayner JC
    PLoS Pathog; 2021 Jul; 17(7):e1008864. PubMed ID: 34197567
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural basis for inhibition of Plasmodium vivax invasion by a broadly neutralizing vaccine-induced human antibody.
    Rawlinson TA; Barber NM; Mohring F; Cho JS; Kosaisavee V; Gérard SF; Alanine DGW; Labbé GM; Elias SC; Silk SE; Quinkert D; Jin J; Marshall JM; Payne RO; Minassian AM; Russell B; Rénia L; Nosten FH; Moon RW; Higgins MK; Draper SJ
    Nat Microbiol; 2019 Sep; 4(9):1497-1507. PubMed ID: 31133755
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Library of Plasmodium vivax Recombinant Merozoite Proteins Reveals New Vaccine Candidates and Protein-Protein Interactions.
    Hostetler JB; Sharma S; Bartholdson SJ; Wright GJ; Fairhurst RM; Rayner JC
    PLoS Negl Trop Dis; 2015 Dec; 9(12):e0004264. PubMed ID: 26701602
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human monoclonal antibodies inhibit invasion of transgenic Plasmodium knowlesi expressing Plasmodium vivax Duffy binding protein.
    Watson QD; Carias LL; Malachin A; Redinger KR; Bosch J; Bardelli M; Baldor L; Feufack-Donfack LB; Popovici J; Moon RW; Draper SJ; Zimmerman PA; King CL
    Malar J; 2023 Dec; 22(1):369. PubMed ID: 38049801
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibodies raised against receptor-binding domain of Plasmodium knowlesi Duffy binding protein inhibit erythrocyte invasion.
    Singh AP; Puri SK; Chitnis CE
    Mol Biochem Parasitol; 2002 Apr; 121(1):21-31. PubMed ID: 11985860
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of the precision of the Plasmodium knowlesi growth inhibition assay for Plasmodium vivax Duffy-binding protein-based malaria vaccine development.
    Mertens JE; Rigby CA; Bardelli M; Quinkert D; Hou MM; Diouf A; Silk SE; Chitnis CE; Minassian AM; Moon RW; Long CA; Draper SJ; Miura K
    Vaccine; 2024 Jun; 42(16):3621-3629. PubMed ID: 38704253
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cross-species reactivity of antibodies against Plasmodium vivax blood-stage antigens to Plasmodium knowlesi.
    Muh F; Kim N; Nyunt MH; Firdaus ER; Han JH; Hoque MR; Lee SK; Park JH; Moon RW; Lau YL; Kaneko O; Han ET
    PLoS Negl Trop Dis; 2020 Jun; 14(6):e0008323. PubMed ID: 32559186
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasmodium vivax invasion of human erythrocytes inhibited by antibodies directed against the Duffy binding protein.
    Grimberg BT; Udomsangpetch R; Xainli J; McHenry A; Panichakul T; Sattabongkot J; Cui L; Bockarie M; Chitnis C; Adams J; Zimmerman PA; King CL
    PLoS Med; 2007 Dec; 4(12):e337. PubMed ID: 18092885
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rapid and iterative genome editing in the malaria parasite
    Mohring F; Hart MN; Rawlinson TA; Henrici R; Charleston JA; Diez Benavente E; Patel A; Hall J; Almond N; Campino S; Clark TG; Sutherland CJ; Baker DA; Draper SJ; Moon RW
    Elife; 2019 Jun; 8():. PubMed ID: 31205002
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunogenicity of single versus mixed allele vaccines of Plasmodium vivax Duffy binding protein region II.
    Ntumngia FB; Schloegel J; McHenry AM; Barnes SJ; George MT; Kennedy S; Adams JH
    Vaccine; 2013 Sep; 31(40):4382-8. PubMed ID: 23916294
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A panel of recombinant proteins from human-infective Plasmodium species for serological surveillance.
    Müller-Sienerth N; Shilts J; Kadir KA; Yman V; Homann MV; Asghar M; Ngasala B; Singh B; Färnert A; Wright GJ
    Malar J; 2020 Jan; 19(1):31. PubMed ID: 31952523
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Naturally acquired Duffy-binding protein-specific binding inhibitory antibodies confer protection from blood-stage Plasmodium vivax infection.
    King CL; Michon P; Shakri AR; Marcotty A; Stanisic D; Zimmerman PA; Cole-Tobian JL; Mueller I; Chitnis CE
    Proc Natl Acad Sci U S A; 2008 Jun; 105(24):8363-8. PubMed ID: 18523022
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting a Reticulocyte Binding Protein and Duffy Binding Protein to Inhibit Reticulocyte Invasion by Plasmodium vivax.
    Gupta S; Singh S; Popovici J; Roesch C; Shakri AR; Guillotte-Blisnick M; Huon C; Menard D; Chitnis CE
    Sci Rep; 2018 Jul; 8(1):10511. PubMed ID: 30002416
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibody responses and avidity of naturally acquired anti-Plasmodium vivax Duffy binding protein (PvDBP) antibodies in individuals from an area with unstable malaria transmission.
    Zakeri S; Babaeekhou L; Mehrizi AA; Abbasi M; Djadid ND
    Am J Trop Med Hyg; 2011 Jun; 84(6):944-50. PubMed ID: 21633032
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Natural acquired inhibitory antibodies to Plasmodium vivax Duffy binding protein (PvDBP-II) equally block erythrocyte binding of homologous and heterologous expressed PvDBP-II on the surface of COS-7 cells.
    Valizadeh V; Zakeri S; Mehrizi AA; Mirkazemi S; Djadid ND
    Med Microbiol Immunol; 2016 Feb; 205(1):85-95. PubMed ID: 26243337
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical expression and antigenic profiles of a Plasmodium vivax vaccine candidate: merozoite surface protein 7 (PvMSP-7).
    Cheng CW; Jongwutiwes S; Putaporntip C; Jackson AP
    Malar J; 2019 Jun; 18(1):197. PubMed ID: 31196098
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Multi-Stage
    McCaffery JN; Fonseca JA; Singh B; Cabrera-Mora M; Bohannon C; Jacob J; Arévalo-Herrera M; Moreno A
    Front Cell Infect Microbiol; 2019; 9():135. PubMed ID: 31119106
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Non-allele specific antibody responses to genetically distinct variant forms of Plasmodium vivax Duffy binding protein (PvDBP-II) in Iranians exposed to seasonal malaria transmission.
    Valizadeh V; Zakeri S; Mehrizi AA; Djadid ND
    Acta Trop; 2014 Aug; 136():89-100. PubMed ID: 24704284
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of an Immunogenic Broadly Inhibitory Surface Epitope of the Plasmodium vivax Duffy Binding Protein Ligand Domain.
    George MT; Schloegel JL; Ntumngia FB; Barnes SJ; King CL; Casey JL; Foley M; Adams JH
    mSphere; 2019 May; 4(3):. PubMed ID: 31092602
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting the Plasmodium vivax Duffy-binding protein.
    Chitnis CE; Sharma A
    Trends Parasitol; 2008 Jan; 24(1):29-34. PubMed ID: 18023618
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.